Asian medical “saving innovationâ€
Release date: 2014-05-20
In the post-industrial era, faced with the thorny world economy and the end of the business model, we need to find new ways to deal with the challenges of innovation. When innovation in the traditional capitalist market has been criticized, can innovative business models in emerging countries replicate globally? The Innovator's Challenge, recommended in this issue, reveals how disruptive innovation can transform individuals, businesses, and nations.
In the early morning of the morning, I walked into the heart surgery room of Warkhardt Hospital in Bangalore. A middle-aged Indian man lay on the operating table and looked calm. When asked about the situation, he replied with a smile in Kannada. "It feels good." However, the visitor stood on the stool and saw that the patient's chest was clearly completely cut.
It turned out that while the patient was pulling, Vivek Jawali and his surgery team had already completed this complicated and sophisticated heart bypass surgery. Because this thrilling surgery is painless and does not require general anesthesia or anticoagulants, patients can quickly walk down the ground. This method was pioneered by Walker Hart Hospital and has been successfully used in many operations, attracting a large number of tourists from all over the world to come to Bangalore for medical treatment.
This is just one example of India's outstanding innovation in this industry. Nowadays, private medical entrepreneurs are guiding the country's rich technology and human resources to the study of economical engineering technology, which deserves the envy of the smug medical system in developed countries. Although Jawary has been hailed as a medical pioneer, he still clearly remembers that Western counterparts have been ridiculing the new surgical techniques they have advocated for years.
Jawari said that unlike the rigid and rigid medical system in developed countries, “you must innovate in a patient-centered medical system,†but this is not to say that all fancy new devices are coming. For several years, he has refused surgery robots and laparoscopic instruments because its cost exceeds the estimated benefits. Instead, he has been looking for tools and techniques to save resources and do more with less.
Futong Health is also a chain hospital group in India, headquartered in New Delhi, and has acquired the Walker Hart Group, completing a step in its grand pan-Asia expansion strategy. Its boss, Sheryl Singer, further confirmed that Western technology-based multinationals have long forgotten the art of conservation-oriented engineering. At the same time, the vast market occupied by low-end hospitals with less capital has been ignored.
It is not only Singh who believes that many medical centers and multinational companies in developed countries have misconceptions about innovation. Paul York, head of the Stanford University Biodesign Lab, believes that in the past, medical technology giants such as Philips and Medtronic in the US “have only demanded, but ignore costsâ€. As the public is increasingly worried that the cost of health care will lead to hyperinflation, the business model has brought huge profits to Western medical technology companies such as Medtronic, but it has “can no longer functionâ€.
York firmly believes that the only way forward is to disrupt the innovation process in the industry. He taught his graduate students that cost-effectiveness should be considered early in the entire process of invention. The key is the first step in innovation, which is to discover market gaps, rather than first researching novelty technologies and then looking for demand. He found inspiration in India. He believes that through its combination of technical talent and cost constraints, the country will create a world-class medical device industry. Therefore, not long ago he extended Stanford's design project to this South Asian subcontinent.
Although mentioning medical innovation in India, people may first think of generic drugs. But in fact, many relatively unknown examples are emerging in the country's health system. Invention companies are investigating new medical devices, communication technologies and smart business models, and integrating all of these innovations into new ways to achieve affordable healthcare. The medical needs of a large number of poor people are difficult to solve, and the vibrant private medical industry has found huge business opportunities, and the combination of the two has formed a catalyst for innovation.
At present, emerging market countries such as China and India are rapidly moving up the value chain with independent innovations that are often ingenious. We must pay attention to these whimsical Eastern engineers, because their economical innovation will push their companies to the forefront of the global industry. Nearly one-tenth of the Fortune Global 500 companies selected by Fortune magazine are Chinese companies. The Indian giant Tata not only developed an attractive “Nano car†with a cost of less than US$4,000, but also shocked the auto industry by acquiring Jaguar and Land Rover.
On the one hand, the rapidly expanding middle class has a certain disposable income, while the demand for quality of life is also increasing, thus creating a profitable market. On the other hand, most people in these countries still remember the life of poverty – which means that companies must save on operating costs and use less resources to produce cheap products.
In the United States and other rich countries, the health care, energy, automotive and other industries have dominated for a while, but now it is problem-ridden. However, Asia's disruptive wave of innovative innovation is also good news for the middle class in these countries. It is commendable that the Western giants have responded, making huge investments in these fast-growing emerging markets, and apparently learning useful techniques from these conservation-conscious locals. But the giants are reluctant to bring these high-quality and low-cost technologies back to developed countries, and this is exactly what the bloated medical system in the United States and other countries really need.
If American companies can't afford to eat their own bowl of rice, the up-and-coming talents of the Asian medical technology industry will soon be replaced. The only real question now is whether the future of the innovative innovative talents that stand out in the future is with forks and knives.
Source: Bio-Exploration
China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com